Lung tumors are difficult to remove using current surgical techniques due to their location in the lung. Also, there are multiple tumors which are too small to observe. They develop natural barriers…
10 Simple Ways to Reduce the Risk of Lung Cancer
Though not all lung cancers can be prevented, but there are things that one can do to reduce the risk of lung cancer. Lung cancer is considered as smoker’s disease but people…
Non-Smoking Lung Cancer Patients May Respond Differently to Treatment
Although smoking remains the main cause of lung cancer for most of the patients but there are other factors as well which may cause lung cancer. Non-smokers are also being getting trapped…
Ginger May Help Fight Lung Cancer
When one is undergoing lung cancer treatment, the taste diminishes or even changes. The patient goes through a lot of mental, physical as well as psychological changes in the body. When it…
Anti-Cancer Properties of Saffron to help Lung Cancer Patients
Lung cancer is the most common form of cancer worldwide. It is not only difficult to cure but also has a high incidence of recurrence. Thus, the development of effective anti-cancer strategies…
Near-Infrared Light Treatment for A Rare Form Of Lung Cancer
Nagoya University oncologist Kazuhide Sato and team have tested the treatment for a rare type of malignant lung cancer and published its findings in the journal Cells. The team has worked to…
Is Cinnamon Beneficial for Lung Cancer Patients?
Cinnamon is one of the oldest known spices and has a naturally sweet flavor. It is obtained from the inner bark of several tree species. It is widely used in Ayurveda and…
Study: Nicotine May Promote Brain Tumors in Lung Cancer Patients
According to a new study, researchers have found that nicotine actually promotes the spread of lung cancer cells into the brain where they can form deadly metastatic tumors. Nicotine is a non-carcinogenic…
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletions or exon 21 mutations….
Alunbrig Gets FDA Approval for Frontline ALK-Positive Lung Cancer Patients
FDA has approved Alunbrig or Brigatinib for first-line treatment of patients with ALK-positive metastatic non-small cell lung cancer, as detected by FDA-approved test. This approval has been based on phase III ALTA-1L trial….
U.S. FDA Gives Nod To Bristol-Myers Combo Therapy For Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases. Lung cancer patients in advanced stages of the disease have received a new first-line treatment option. The U.S. Food…
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most common type of lung…